The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy

  • Zvi Shimoni Department of Internal Medicine B, Laniado Hospital, Netanya, Israel.
  • Hanna Bin National Center for Zoonotic Viruses, Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical, Tel-Hashomer, Israel.
  • Shlomo Bulvik Department of Hematology, Laniado Hospital, Netnaya, Israel.
  • Mark Niven Department of Internal Medicine B, Laniado Hospital, Netanya, Israel.
  • Rawi Hazzan Department of Internal Medicine D,Rabin Medical Center Campus Beilinson, Petah Tikva, Israel.
  • Ella Mendelson Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical, Tel-Hashomer, Israel.
  • Paul Froom | froomp@gmail.com Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University, Ramat Aviv, Israel.

Abstract

The aim of the study was to determine whether intravenous gamma globulin (IVIG) treatment is effective in patients with West Nile Virus (WNV) neuroinvasive disease. We contacted hospital based infectious disease experts in Israeli hospitals to identify patients with WNV neuroinvasive disease who were treated with IVIG. The main outcome measure was neurological response after treatment. There were 12 patients who received IVIG and four improved within 48 h. Three patients died, 6 had partial recovery, and 3 recovered completely. Eleven of the 12 patients were infected with Israeli genotypes that are highly homologous to Europe/Africa viruses. The rapid response in some patients suggests that IVIG is effective, and might be used to treat patients with WNV neuroinvasive disease with IVIG.

Google Scholar

Google Scholar

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Author Biography

Zvi Shimoni, Department of Internal Medicine B, Laniado Hospital, Netanya
Associate Professor School of Public Health Department of Epidemiology
Published
2012-01-27
Info
Issue
Section
Brief Reports
Keywords:
IVIG, West Nile virus, neuroinvasive disease, case series.
Statistics
  • Abstract views: 1224

  • PDF: 681
  • HTML: 75
How to Cite
Shimoni, Z., Bin, H., Bulvik, S., Niven, M., Hazzan, R., Mendelson, E., & Froom, P. (2012). The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy. Clinics and Practice, 2(1), e18. https://doi.org/10.4081/cp.2012.e18